Search Results

Business

AdvanCell Expands Leadership Team with the Appointment of Christopher Horvath, MS MBA, as Chief Commercial Officer & Chief Operating Officer and Gary Li, PhD, as Chief Strategy Officer

AdvanCell today announced the appointment of two senior management team members.

May 8, 2024

·

3 min read

Business

AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of Anna Karmann, MD, PhD as the company’s Chief Medical Officer based in San Francisco.

January 4, 2024

·

2 min read

AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer

AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients, today announced the first patient was treated with 212Pb-ADVC001, a Targeted Alpha Therapy in development for the treatment of PSMA-positive metastatic Castration-Resistant Prostate Cancer (mCRPC).

November 7, 2023

·

3 min read

male hands with wrist watch is considered American dollars. Hands holding dollar cash. 1000 dollars in 100 bills in a man's hand close-up on a dark background. hundred

Business

Money on the Move: AdvanCell, eTheRNA, Bluejay and More

Money is now flowing into promising platforms for prostate cancer from AdvanCell, mRNA therapeutics from eTheRNA, hepatitis from Bluejay and more.

August 24, 2022

·

5 min read

·

Tristan Manalac

AdvanCell Closes A$18M Series B Funding Led by Morningside

AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, announced the closing of an A$18 million Series B financing round led by Morningside.

August 23, 2022

·

4 min read

Business

POINT Biopharma and AdvanCell to Collaborate in the Development of Lead-212-Labeled Radioligands

POINT Biopharma Global Inc. today announced a collaboration on the development of a global 212 Pb radioisotope and radioligand supply chain and drug manufacturing network to specifically support the clinical development and commercialization of 212Pb-labeled radioligands by each company.

June 26, 2023

·

7 min read

Business

ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced the appointment of Danielle Meyrick, PhD, MD, as Chief Medical Officer.

May 7, 2024

·

4 min read

Business

ADMEcell Enters into Agreement with Advancell

March 13, 2009

·

2 min read

Drug Development

Advancell Announces Promising Phase I/IIa Results with Acadra(R) in CLL

February 15, 2011

·

1 min read

Business

ADMEcell Enters into an Agreement To Exclusively Manufacture and Distribute Advancell’s CacoReady(TM) System throughout North America

February 23, 2009

·

2 min read